Most lately, it's been identified that conolidine and the above derivatives act around the atypical chemokine receptor 3 (ACKR3. Expressed in very similar locations as classical opioid receptors, it binds to the wide array of endogenous opioids. Not like most opioid receptors, this receptor acts as being a scavenger https://anciusn864lmm4.wikisona.com/user